XML 12 R2.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
$ in Thousands
Jun. 30, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 16,516 $ 25,802
Short-term investments 24,117 33,481
Accounts receivable, net 79,931 78,881
Inventory, net 72,965 53,160
Prepaid expenses and other current assets 17,394 17,690
Total current assets 210,923 209,014
Property and equipment, net 13,683 14,863
Right-of-use lease assets 1,401 2,787
Other assets 6,083 6,483
Total assets 232,090 233,147
Current liabilities:    
Accounts payable 12,037 11,709
Accrued clinical and manufacturing liabilities 17,135 25,402
Accrued payroll and employee liabilities 6,471 9,554
Notes payable, net 25,398  
Convertible notes payable, net 149,806  
Other accrued liabilities 46,215 41,755
Current lease liabilities 1,539 3,037
Total current liabilities 258,601 91,457
Non-current notes payable, net   25,026
Non-current convertible notes payable, net   149,700
Other non-current liabilities 747 615
Total liabilities 259,348 266,798
Stockholders' deficit:    
Common stock 1,533 1,521
Additional paid-in capital 1,890,550 1,884,409
Accumulated other comprehensive (loss) income (1) 13
Accumulated deficit (1,919,340) (1,919,594)
Total stockholders' deficit (27,258) (33,651)
Total liabilities and stockholders' deficit $ 232,090 $ 233,147